NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Watchmaker Genomics

Watchmaker Genomics

Private
Boulder, ColoradoHealthcare & Life Scienceshttps://www.watchmakergenomics.com/

Last Round

Series A

Jun 2, 2022

Est. Valuation

$242.25M

Total Funding Raised

$53.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Watchmaker Genomics is a biotechnology company that develops high-performance tools for genomics, molecular diagnostics, and personalized medicine by combining computational biology, protein engineering, and large-scale enzyme manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

next-generation sequencingNGSlibrary preparationDNA methylationmolecular diagnosticsgenomic reagentsTAPS+enzyme engineeringgenomics kitswet-lab reagentsmolecular biology toolsCRISPR normalizationsequencing workflowbiotech consumablesgenomics supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Watchmaker Genomics Comparables

Compare Watchmaker Genomics with similar companies based on industry and business-model similarity.

Watchmaker Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Paragon Genomics
82%
SeqWell
80%
biomodal
79%

Watchmaker Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 2, 2022
SeedDec 4, 2020

Key People

Founding team and executive leadership

Trey Foskett

Co-Founder And Chief Executive Officer

Founding Team

Watchmaker Genomics Investors

Notable investors and investment history

Watchmaker Genomics investors
InvestorRounds
Eclipse VenturesSeries A
Decheng CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Attended ESCMID Global congress to showcase infectious disease diagnostics.

  • Apr 14, 2026

    Expanded MDx tools portfolio with Stellar RT-qPCR and qPCR Kits.

Watchmaker Genomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Watchmaker Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Watchmaker Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range264
Year Founded2019
Last FundingJun 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.